Michael W Long Email & Phone Number

Northville, MI, US

Rochester Hills, Michigan, United States

Responsible for all research misconduct activities; overseeing misconduct committees, misconduct verification and evidence acquisition, liaison with Chief Research Officer, Chairs and Deans of case-specific departments

Roshester Hills MI

Oversight and support of the University’s regulatory committees: Export Control, Financial Conflict of Interest (FCOI), Foreign Influence, Human Pluripotent Stem Cell Research Oversight (HPSCRO) Committee, Institutional Animal Care and Use Committee (IACUC), Institutional Biosafety Committee (IBC), Radiation Safety (RSC), and Responsible Conduct of Research

The MZ is a University wide program that integrates faculty, students, and facilities with regional goverments to promote economic development.

Rochester Hills, MI

Member of the Office or Research Administration. Assisting the University, faculty and students in their commercialization efforts.

Alturus Biomedicine is a development company that both starts Life Science companies and helps those in existence grow. Alturus has worked with a broad range of companies from start up to major biopharmaceutical corporations both in the US and internationally.

College Of Veterinary Medicine

Mentor Doctoral students, advise on research directions and data analysis. Consultation and advise the Comparative Orthopedic Research Laboratory.

Founded FreeStride Therapeutics, a company that develops FDA-approved drugs for veterinary use, focusing on thoroughbred horses with later extension to other companion animals. Recruited SMT, raised initial Seed round, and developed FDA, commercial and academic partnerships to further company development.

Oversaw all start-up operations, including budget development, business plan development, capital acquisition, etc. Planned and executed three animal clinical studies on a therapy for Thoroughbred race horse lameness.

Founded company to develop a portfolio of bone therapy programs. In-licensed and developed to clinical-phase a highly effective molecule for Rheumatoid Arthritis. Built company’s business development and licensing function, including strategic direction, team formation and execution of a partnering initiative. Led senior scientific/commercial team to.

Many years of volunteer experience with the Society a $300 Million per year non-profit organization; first as a member of Medical & Scientific Board, then as a National Board of Directors member and finally as a member of the Society's Executive Committee (overlapping terms). Multiple committees and oversight responsibilities there involved CEO selection.

Research in the areas of cell and molecular biology and received more than $15 million in funding from the National Institutes of Health. As a professor, developed the technology for bone cell analysis and for forming human bone outside the body, ultimately generating 15 patents as the primary inventor. Member (4 years ) the Hematology scientific review.

Msc, Phd, Human Physiology

Program On Negotiations: Executive Negotiations

Executive Finances